Saturday, January 08, 2022 11:34:25 AM
solil, Thank you, and I hope it all works VERY out well for ALL of us, but unfortunately I have lost much confidence in neuro because of what appears to me to be clearly a lack of cooperation with RLF. Even the neuro press releases seem to usually fail to mention that RLF is a partner, not to mention the previous failures in the submissions to the FDA.
Other concerns seems to be RLF is the giver and NRXP is the taker in this relationship so far.
I felt forced to divest my modest neuro position, esp when a new small company like neuro has become entangled in so many lawsuits and investigations, right out of the starting gate.
An excellent resolution and a close working relationship between the two companies, I feel, is very necessary, but my concern is the positions seem to be hardening and neuro is moving even further apart.
Other concerns seems to be RLF is the giver and NRXP is the taker in this relationship so far.
I felt forced to divest my modest neuro position, esp when a new small company like neuro has become entangled in so many lawsuits and investigations, right out of the starting gate.
An excellent resolution and a close working relationship between the two companies, I feel, is very necessary, but my concern is the positions seem to be hardening and neuro is moving even further apart.
My opinion is reflected in my posts, and it is never advice to buy, sell or trade any securities. Do your own due diligence before purchasing anything in the stock market.
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
